| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.25 | 0.003 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.007 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.01 |